Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.

Health experts in Kenya have raised an alarm over the severe shortage of Bacillus Calmette-Guérin (BCG), the life-saving childhood vaccine that has been out of stock in government stores and hospitals ...

Scientists have developed a breakthrough mechanism that makes the intravenous Bacillus Calmette-Guérin (BCG) tuberculosis ...

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...

The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.

A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...

Counties are facing limited supplies or no stock at all, leaving newborns vulnerable to TB. Health advocates are urging the ...

A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in ...

Bacillus Calmette-Guérin (BCG) vaccine – named for its developers ... it provides only partial protection against TB in young children and no protection in adults. To develop a more universally ...